+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Jiuerxin Capsule Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129154
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Jiuerxin Capsule is reshaping treatment strategies in the cardiovascular therapeutics market, offering a controlled-release solution that aligns closely with the surge in demand for patient-centered care and regulatory-backed innovations. For senior decision-makers, this evolving landscape presents new opportunities to optimize supply chains and deliver differentiated outcomes across diverse healthcare environments.

Market Snapshot: Jiuerxin Capsule Industry Overview

The Jiuerxin Capsule market is gaining momentum as advanced cardiovascular therapeutics continue to address evolving patient requirements. With strong regulatory support and rapid adoption of innovative formulations, companies are leveraging robust distribution networks and digital solutions to extend reach. Growth is propelled by strategic investments in personalized medicine, regional partnerships, and sustained engagement from healthcare payers.

Scope & Segmentation

This analysis explores the Jiuerxin Capsule market across all key segments and territories, highlighting connectivity between supply chain nodes and adoption drivers.

  • Distribution Channels: E-commerce portals, hospital pharmacies (private and public), and retail pharmacies supporting both inpatient and outpatient needs.
  • End Users: Clinics (including small and specialized settings), home care providers, and hospitals managing acute and chronic hypertension.
  • Dosage Strengths: Up to 10mg, 11–20mg, and 21mg and above, facilitating customized treatment regimens based on patient profiles.
  • Applications: Primary hypertension management and secondary hypertension associated with comorbid conditions.
  • Form Types: Multi-layer capsules for controlled kinetics and single-unit capsules designed for specific adherence strategies.
  • Geographic Coverage: Americas (United States regions, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, France, UAE, South Africa, and others), and Asia-Pacific (notably China, India, Japan, Australia, and regional manufacturing hubs).

Key Takeaways for Decision-Makers

  • Jiuerxin Capsule’s multi-layer delivery harnesses targeted pharmacological pathways, enabling consistent bioavailability and extended plasma concentrations by design.
  • The product’s release profile minimizes dosing frequency and supports improved patient compliance, aligning with modern adherence monitoring trends and integration of remote care technologies.
  • Mechanistically, Jiuerxin Capsule is positioned as a differentiated therapy due to its dual emphasis on vascular modulation and renal preservation, with growing evidence of effectiveness among patients with complex metabolic comorbidities.
  • Technological advances and regulatory reforms are accelerating flexible approval pathways, inviting strategic partnerships between biotech leaders and research institutions for integrated development and real-world data generation.
  • Regional adoption reflects varied reimbursement frameworks and healthcare infrastructure, requiring local partnerships and agile distribution models to unlock penetration in emerging and consolidated health systems.
  • Competitive strategies include investment in IP management, expansion of local manufacturing, and deployment of tailored educational and patient support programs to maintain market visibility.

Tariff Impact on Supply Chain and Pricing

The 2025 United States tariffs introduced substantial cost pressures across the Jiuerxin Capsule supply chain, notably on active pharmaceutical ingredient sourcing. Organizations responded with supplier contract revisions, logistics optimization, and regional nearshoring to adapt to evolving import duties. Pricing strategies are being recalibrated to preserve market access while containing cost escalation, highlighting the necessity of resilient, diversified procurement models.

Methodology & Data Sources

This report utilizes primary interviews with cardiovascular clinicians, regulatory authorities, and procurement experts, corroborated by secondary sources including peer-reviewed journals, regulatory guidelines, patent filings, and industry white papers. Cross-validation and analytical modeling ensure reliability and actionable insight throughout the report.

Why This Report Matters

  • Supports executive strategies by correlating technology adoption, regulatory shifts, and emerging patient care paradigms specific to the Jiuerxin Capsule market.
  • Guides supply chain resilience, partnership models, and lifecycle innovation planning amidst evolving regulatory and tariff landscapes.

Conclusion

Jiuerxin Capsule is advancing the standard of care in hypertension therapeutics. This report details actionable strategies, regional dynamics, and competitive developments to help decision-makers drive sustainable growth and navigate complex market changes with confidence.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of Jiuerxin Capsule in integrative cardiology protocols for ischemic heart disease treatment
5.2. Surge in clinical trials evaluating safety and efficacy of Jiuerxin Capsule for stable angina patients
5.3. Impact of updated national traditional Chinese medicine guidelines on Jiuerxin Capsule prescribing trends in hospitals
5.4. Expansion of multi channel distribution network for Jiuerxin Capsule including e commerce and hospital pharmacies
5.5. Increasing consumer preference for herbal cardiovascular treatments driving demand for Jiuerxin Capsule in domestic market
5.6. Integration of real world evidence studies to support Jiuerxin Capsule regulatory approvals across new markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Jiuerxin Capsule Market, by Distribution Channel
8.1. Introduction
8.2. E-Commerce
8.3. Hospital Pharmacy
8.3.1. Private Hospitals
8.3.2. Public Hospitals
8.4. Retail Pharmacy
9. Jiuerxin Capsule Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Small Clinics
9.2.2. Specialized Clinics
9.3. Home Care
9.4. Hospitals
10. Jiuerxin Capsule Market, by Dosage Strength
10.1. Introduction
10.2. 11-20Mg
10.3. 21Mg And Above
10.4. Up To 10Mg
11. Jiuerxin Capsule Market, by Application
11.1. Introduction
11.2. Hypertension
11.2.1. Primary
11.2.2. Secondary
12. Jiuerxin Capsule Market, by Form Type
12.1. Introduction
12.2. Multi-Layer Capsule
12.3. Single Capsule
13. Americas Jiuerxin Capsule Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Jiuerxin Capsule Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Jiuerxin Capsule Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Jiangsu Kanion Pharmaceutical Co., Ltd.
16.3.2. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
16.3.3. Tasly Pharmaceutical Group Co., Ltd.
16.3.4. Harbin Pharmaceutical Group Co., Ltd.
16.3.5. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
16.3.6. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
16.3.7. Yunnan Baiyao Group Co., Ltd.
16.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.
16.3.9. Hubei Biocause Pharmaceutical Co., Ltd.
16.3.10. Shandong Buchang Pharmaceuticals Co., Ltd.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. JIUERXIN CAPSULE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL JIUERXIN CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. JIUERXIN CAPSULE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. JIUERXIN CAPSULE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. JIUERXIN CAPSULE MARKET: RESEARCHAI
FIGURE 26. JIUERXIN CAPSULE MARKET: RESEARCHSTATISTICS
FIGURE 27. JIUERXIN CAPSULE MARKET: RESEARCHCONTACTS
FIGURE 28. JIUERXIN CAPSULE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. JIUERXIN CAPSULE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL JIUERXIN CAPSULE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL JIUERXIN CAPSULE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SMALL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY 11-20MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY 11-20MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY 21MG AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY 21MG AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY UP TO 10MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY UP TO 10MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY PRIMARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SECONDARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SECONDARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY MULTI-LAYER CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY MULTI-LAYER CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SINGLE CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL JIUERXIN CAPSULE MARKET SIZE, BY SINGLE CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES JIUERXIN CAPSULE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 100. CANADA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 101. CANADA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. CANADA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. CANADA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. CANADA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. CANADA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. CANADA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 110. CANADA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 111. CANADA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 122. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 123. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA JIUERXIN CAPSULE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 211. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 243. ITALY JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ITALY JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ITALY JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. ITALY JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. ITALY JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ITALY JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. ITALY JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. ITALY JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. ITALY JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. ITALY JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ITALY JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ITALY JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 256. ITALY JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 257. ITALY JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 259. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 323. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 336. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2025-2030 (USD MILLION)
TABLE 337. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2018-2024 (USD MILLION)
TABLE 338. DENMARK JIUERXIN CAPSULE MARKET SIZE, BY FORM TYPE, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS JIUERXIN CAPSULE MARKET SIZE, BY HYPERTENSION, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS JIUERXIN CAPSULE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Jiuerxin Capsule Market report include:
  • Jiangsu Kanion Pharmaceutical Co., Ltd.
  • Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Tasly Pharmaceutical Group Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd.
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Hubei Biocause Pharmaceutical Co., Ltd.
  • Shandong Buchang Pharmaceuticals Co., Ltd.